Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a lower HIV drug dose work just as well?

NCT ID NCT02384967

First seen Apr 04, 2026 · Last updated May 22, 2026 · Updated 7 times

Summary

This study tested whether reducing the daily dose of the HIV drug darunavir from 800 mg to 400 mg could keep the virus suppressed in 100 adults who already had undetectable viral loads. Participants were on a stable regimen including darunavir and two other drugs. The goal was to see if the lower dose maintained viral suppression below 50 copies/mL at 48 weeks. This is a disease control study, not a cure, as lifelong medication is still needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hôpital Saint Louis

    Paris, 75010, France

Conditions

Explore the condition pages connected to this study.